AZTR Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -9.91%, SMA50 -28.95%, SMA200 -78.84%). The stock’s 14-day RSI is 35.0 (weak momentum), while the ATR of 0.02 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -93.17% below its high and over 17.34% above its low. Average 10-day trading volume of 12.43 million shares is significantly above the 3-month average of 2.94 million, indicating heightened recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Azitra, Inc. (AMEX:AZTR) closed at $0.28 USD, gaining $0.11 (60.59%) from the previous close of $0.18. The stock is currently mid-range between its 52-week high and low $0.10 and $2.67. With a market capitalization of about $3.04 million, Azitra, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.50). Key stats such as the average daily volume over the past year has been around 1.50 million shares, trading with heavier-than-usual volume. Headquartered in Branford, CT, Azitra, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Francisco D. Salva, the company employs approximately 12 people and listed since June 20, 2023. Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Wall Street analysts project EPS growth of 43.57% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $4.00 to $4.00. The high target offers 2122.22% upside. The low target suggests 2122.22% downside. The mean target is $4.00. This offers 2122.22% upside. Azitra, Inc. earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by -15.19%. The prior quarter beat by -14.29%. Over the last six quarters, Apple has recorded several small beats. These include 94.44% in March 15, 2024.

Azitra, Inc. has 10.74 million shares outstanding. The public float is 10.19 million shares, elevated short interest at 5.72% of float. This equals 613.71 thousand shares. The short ratio is 0.3 days. Institutional investors hold 0.41% of the float. Insiders own 5.16%. Salva Francisco D. holds 338.30 thousand shares, Whitfill Travis has 334.50 thousand shares and Staskey Norm has 51.10 thousand shares.

Azitra, Inc. trades at a P/E ratio of -0.13, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.37 suggesting the stock is closer to book value. The P/FCF stands at -0.04, also above market averages.

Azitra, Inc. (AMEX:AZTR) shares are up 12.92% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Azitra, Inc. trading at a premium to the broader market with a P/E of -0.13. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $4.00, suggesting 2171.44% upside. Our AI forecast model points to short-term weakness (-9.14% over two weeks), a medium-term fall (-88.64% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Azitra, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -9.14%, with price expected at $0.16 by April 02, 2026, within a range of $0.14 to $0.17 3-Month Outlook: Projected fall of -88.64%, reaching $0.02 by June 17, 2026, with a range of $0.00 to $0.04. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by March 19, 2027, within a range of $0.00 to $0.18.